Fundraising FoxDolinnov
1 known investors
Find your way into Dolinnov
Sign up to see every warm intro you have to Dolinnov
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Dolinnov team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dolinnov is a pharmaceutical company developing next-generation painkillers based on a Precision Pump Modulator that targets the ion pump driving neuronal hyperexcitability rather than blocking ion channels. It focuses on treatments for extreme chronic pain and other serious diseases with significant unmet medical needs.
Founders & leadership
GS
Grégoire SerraFounder & CEOFounder and CEO of Dolinnov, a pharmaceutical company developing next-generation painkillers for extreme chronic pain and other serious diseases. He works on moving preclinical assets into clinical development and building partnerships in the pharmaceutical industry.
Investors · 1
Frequently asked questions
- What does Dolinnov do?
- Dolinnov is a pharmaceutical company developing next-generation painkillers based on a Precision Pump Modulator that targets the ion pump driving neuronal hyperexcitability rather than blocking ion channels. It focuses on treatments for extreme chronic pain and other serious diseases with significant unmet medical needs.
- Who founded Dolinnov?
- Dolinnov was founded by Grégoire Serra.
- Who are Dolinnov's investors?
- Dolinnov's investors include Agoranov.